glp 1 analog drugs GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Understanding GLP-1 receptor agonists and

doi:10.2337/dc11-s231 Jensterle M, Rizzo M, Haluzk M, Jane A

Future Potential : The robust pipeline of increasingly effective agents, combined with emerging oral formulations and potential cost reduction strategies, suggests that current limitations may be surmountable with continued innovation and policy development

As demonstrated in anesthetized pigs, blood concentrations of total and active GLP-1 progressively decrease with increasing distance from the site of secretion [241]

This glucose-dependent modulation provides a built-in safety mechanism

Chewable formulations activate early vagal and mucosal signals, improving downstream microbial colonization and metabolic hormone timing

Most people tolerate both medication types well after initial adjustment